Predicting Activity Cliffs for Autonomous Medicinal Chemistry
Activity cliff prediction - identifying positions where small structural changes cause large potency shifts - has been a persistent challenge in computational medicinal chemistry. This work focuses on a parsimonious definition: which small modifications, at which positions, confer the highest probability of an outcome change. Position-level sensitivity is calculated using 25 million matched molecular pairs from 50 ChEMBL targets across six protein families, revealing that two questions have fundamentally different answers. "Which positions vary most?" is answered by scaffold size alone (NDCG@3 = 0.966), requiring no machine learning. "Which are true activity cliffs?" - where small modifications cause disproportionately large effects, as captured by SALI normalization - requires an 11-feature model with 3D pharmacophore context (NDCG@3 = 0.910 vs. 0.839 random), generalizing across all six protein families, novel scaffolds (0.913), and temporal splits (0.878). The model identifies the cliff-prone position first 53% of the time (vs. 27% random - 2x lift), reducing positions a chemist must explore from 3.1 to 2.1 - a 31% reduction in first-round experiments. Predicting which modification to make is not tractable from structure alone (Spearman 0.268, collapsing to -0.31 on novel scaffolds). The system is released as open-source code and an interactive webapp.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Semi-Supervised GCN for learning Molecular Structure-Activity Relationships
Since the introduction of artificial intelligence in medicinal chemistry, the necessity has emerged to analyse how molecular property variation is modulated by either single atoms or chemical groups. In this paper, we pr…
Drug DesignGraph Neural NetworkMolEvolve: LLM-Guided Evolutionary Search for Interpretable Molecular Optimization
Despite deep learning's success in chemistry, its impact is hindered by a lack of interpretability and an inability to resolve activity cliffs, where minor structural nuances trigger drastic property shifts. Current repr…
Representation LearningRhizome OS-1: Rhizome's Semi-Autonomous Operating System for Small Molecule Drug Discovery
We present Rhizome OS-1, a semi-autonomous operating system for small molecule drug discovery in which multi-modal AI agents operate as a full multidisciplinary discovery team. These agents function as computational chem…
Drug DiscoveryChemistry42: An AI-based platform for de novo molecular design
Chemistry42 is a software platform for de novo small molecule design that integrates Artificial Intelligence (AI) techniques with computational and medicinal chemistry methods. Chemistry42 is unique in its ability to gen…
Drug DiscoveryThe Geometry of Activity Cliffs: Representation Dependence and Multi-Scale Characterization of Activity Landscapes
Activity cliffs, structurally similar compounds with large potency differences, are widely treated as intrinsic features of chemical datasets. We argue that apart from target biology, much of our cliff understanding is a…